Harvard Apparatus Regenerative Technology Inc.
HRGN
$2.18
-$0.17-7.40%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.60% | 402.22% | -15.12% | 108.47% | 466.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.60% | 402.22% | -15.12% | 108.47% | 466.07% |
| Cost of Revenue | 29.47% | 524.24% | 13.71% | 60.00% | 2,223.08% |
| Gross Profit | 53.33% | 66.67% | -75.90% | 200.00% | -65.12% |
| SG&A Expenses | -33.05% | -1.45% | -14.04% | -17.35% | -16.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.05% | 6.82% | 18.11% | -4.22% | 5.55% |
| Operating Income | 7.69% | 3.83% | -24.40% | 7.80% | 7.47% |
| Income Before Tax | 7.02% | 3.50% | -25.52% | 8.60% | 27.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.02% | 3.50% | -25.52% | 8.60% | 27.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.02% | 3.50% | -25.52% | 8.60% | 27.02% |
| EBIT | 7.69% | 3.83% | -24.40% | 7.80% | 7.47% |
| EBITDA | 7.70% | 3.78% | -24.50% | 7.80% | 7.29% |
| EPS Basic | 15.81% | 12.57% | -16.35% | 19.45% | 34.65% |
| Normalized Basic EPS | 15.78% | 12.60% | -16.51% | 19.38% | 18.26% |
| EPS Diluted | 15.81% | 12.57% | -16.35% | 19.45% | 34.65% |
| Normalized Diluted EPS | 15.78% | 12.60% | -16.51% | 19.38% | 18.26% |
| Average Basic Shares Outstanding | 10.44% | 10.44% | 7.90% | 13.42% | 11.65% |
| Average Diluted Shares Outstanding | 10.44% | 10.44% | 7.90% | 13.42% | 11.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |